Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases.

Joosse SA, Müller V, Steinbach B, Pantel K, Schwarzenbach H.

Br J Cancer. 2014 Jul 1. doi: 10.1038/bjc.2014.360. [Epub ahead of print]

PMID:
24983365
[PubMed - as supplied by publisher]
2.

Clinical relevance of circulating cell-free microRNAs in cancer.

Schwarzenbach H, Nishida N, Calin GA, Pantel K.

Nat Rev Clin Oncol. 2014 Mar;11(3):145-56. doi: 10.1038/nrclinonc.2014.5. Epub 2014 Feb 4.

PMID:
24492836
[PubMed - in process]
3.

Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.

Ell B, Mercatali L, Ibrahim T, Campbell N, Schwarzenbach H, Pantel K, Amadori D, Kang Y.

Cancer Cell. 2013 Oct 14;24(4):542-56. doi: 10.1016/j.ccr.2013.09.008.

PMID:
24135284
[PubMed - indexed for MEDLINE]
4.

Circulating nucleic acids as biomarkers in breast cancer.

Schwarzenbach H.

Breast Cancer Res. 2013;15(5):211.

PMID:
24090167
[PubMed - in process]
Free PMC Article
5.

Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.

Eichelser C, Flesch-Janys D, Chang-Claude J, Pantel K, Schwarzenbach H.

Clin Chem. 2013 Oct;59(10):1489-96. doi: 10.1373/clinchem.2013.205161. Epub 2013 Jun 7.

PMID:
23748853
[PubMed - indexed for MEDLINE]
6.

Circulating mitochondrial DNA as biomarker linking environmental chemical exposure to early preclinical lesions elevation of mtDNA in human serum after exposure to carcinogenic halo-alkane-based pesticides.

Budnik LT, Kloth S, Baur X, Preisser AM, Schwarzenbach H.

PLoS One. 2013 May 31;8(5):e64413. doi: 10.1371/journal.pone.0064413. Print 2013.

PMID:
23741329
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Jaundice and pathological liver values].

Schwarzenbach HR.

Praxis (Bern 1994). 2013 Jun 5;102(12):727-9. doi: 10.1024/1661-8157/a001333. Review. German.

PMID:
23735764
[PubMed - indexed for MEDLINE]
8.

[ICAN (intensive care medicine, surgery, anesthesia and emergency medicine): a new section of SGUM (Swiss Ultrasound Medicine Society)].

Schwarzenbach HR, Tuma J.

Praxis (Bern 1994). 2013 Jun 5;102(12):701-2. doi: 10.1024/1661-8157/a001320. German. No abstract available.

PMID:
23735759
[PubMed - indexed for MEDLINE]
9.

Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.

Schwarzenbach H, Eichelser C, Kropidlowski J, Janni W, Rack B, Pantel K.

Clin Cancer Res. 2012 Oct 15;18(20):5719-30. doi: 10.1158/1078-0432.CCR-12-0142. Epub 2012 Sep 25.

PMID:
23014523
[PubMed - indexed for MEDLINE]
Free Article
10.

[«Knobology» (important device settings)].

Rosenberg I, Schwarzenbach HR, Tuma J.

Praxis (Bern 1994). 2012 Sep 5;101(18):1207-12. doi: 10.1024/1661-8157/a001062. German.

PMID:
22945824
[PubMed - indexed for MEDLINE]
11.

[Ultrasound in the musculoskeletal system - possibilities and limits].

Dietschi A, Schwarzenbach HR.

Praxis (Bern 1994). 2012 Sep 5;101(18):1193-5. doi: 10.1024/1661-8157/a001058. German.

PMID:
22945821
[PubMed - indexed for MEDLINE]
12.

[Diagnosis and management of suspected nephrolithiasis in a primary care setting].

Schwarzenbach HR, Jenzer S.

Praxis (Bern 1994). 2012 Sep 5;101(18):1187-92. doi: 10.1024/1661-8157/a001058. Review. German.

PMID:
22945820
[PubMed - indexed for MEDLINE]
13.

[New aspects in sonography of the liver].

Hagara D, Schwarzenbach HR, Cerny A.

Praxis (Bern 1994). 2012 Sep 5;101(18):1161-6. doi: 10.1024/1661-8157/a001063. Review. German.

PMID:
22945816
[PubMed - indexed for MEDLINE]
14.

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival.

Kuhlmann JD, Schwarzenbach H, Wimberger P, Poetsch M, Kimmig R, Kasimir-Bauer S.

BMC Cancer. 2012 Jul 31;12:325. doi: 10.1186/1471-2407-12-325.

PMID:
22849543
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.

Roth C, Stückrath I, Pantel K, Izbicki JR, Tachezy M, Schwarzenbach H.

PLoS One. 2012;7(6):e38248. doi: 10.1371/journal.pone.0038248. Epub 2012 Jun 4.

PMID:
22675530
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Circulating nucleic acids and protease activities in blood of tumor patients.

Schwarzenbach H.

Expert Opin Biol Ther. 2012 Jun;12 Suppl 1:S163-9. doi: 10.1517/14712598.2012.674508. Epub 2012 Apr 16. Review.

PMID:
22506790
[PubMed - indexed for MEDLINE]
17.

Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.

Schwarzenbach H, Milde-Langosch K, Steinbach B, Müller V, Pantel K.

Breast Cancer Res Treat. 2012 Aug;134(3):933-41. doi: 10.1007/s10549-012-1988-6. Epub 2012 Feb 19.

PMID:
22350790
[PubMed - indexed for MEDLINE]
18.

Circulating tumor cells and circulating tumor DNA.

Alix-Panabières C, Schwarzenbach H, Pantel K.

Annu Rev Med. 2012;63:199-215. doi: 10.1146/annurev-med-062310-094219. Epub 2011 Nov 2. Review.

PMID:
22053740
[PubMed - indexed for MEDLINE]
19.

Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.

Schwarzenbach H, Müller V, Milde-Langosch K, Steinbach B, Pantel K.

Mol Biosyst. 2011 Oct;7(10):2848-54. doi: 10.1039/c1mb05197k. Epub 2011 Jul 22.

PMID:
21785770
[PubMed - indexed for MEDLINE]
20.

Impact of physical activity and doping on epigenetic gene regulation.

Schwarzenbach H.

Drug Test Anal. 2011 Oct;3(10):682-7. doi: 10.1002/dta.294. Epub 2011 Jun 14. Review.

PMID:
21671428
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk